Full-Time

Clinical Research Scientist

Confirmed live in the last 24 hours

Ceribell

Ceribell

201-500 employees

EEG devices for monitoring brain activity

Healthcare

Compensation Overview

$100k - $130kAnnually

+ Bonus + Equity

Junior, Mid

Sunnyvale, CA, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Master’s Degree in science or biomedical engineering
  • 2+ years of relevant experience in data analysis and/or clinical research
  • Experience analyzing complex data and presenting it to varying levels of audience
  • Experience writing peer-reviewed journal articles
  • Ability (and desire) to effectively manage multiple projects in fast-paced startup environment
Responsibilities
  • Supporting evidence generation process from evidence gap analysis through study concept, protocol development, data collection, data analysis, and final write-up.
  • Analyzing retrospective and prospective clinical study datasets to further Ceribell’s evidence generation activities.
  • Authoring manuscripts and abstracts for submission and publication in peer reviewed scientific journals; and authoring slide and poster presentations for scientific meetings/congresses worldwide.
  • Building and maintaining strong relationships with internal and external scientific, technical, and organizational leaders to support clinical and product strategies including study and site clinicians and investigators.
  • Representing Ceribell at scientific conferences and with regulatory agencies, investigational meetings, and Advisory Boards.
  • Contributing as part of the Clinical Research team to determine appropriate evaluation, interpretation, and presentation of data.

Ceribell develops medical devices that use electroencephalogram (EEG) technology to monitor brain activity, with their main product being the Ceribell EEG Headband and Recorder. These devices are used by trained healthcare providers to collect data essential for diagnosing and treating neurological conditions, particularly in urgent cases like Nonconvulsive Status Epilepticus (NCSE). Unlike some competitors, Ceribell's devices do not provide diagnostic conclusions or automated alerts; they simply gather data for healthcare professionals to interpret. The company generates revenue by selling these EEG devices to healthcare providers, with sales regulated to ensure they are made through or by a physician.

Company Stage

Series C

Total Funding

$146.9M

Headquarters

Mountain View, California

Founded

2014

Growth & Insights
Headcount

6 month growth

7%

1 year growth

23%

2 year growth

57%
Simplify Jobs

Simplify's Take

What believers are saying

  • AI-powered algorithms enhance diagnostic accuracy and speed in Ceribell's EEG devices.
  • The global EEG devices market is projected to grow at a CAGR of 8.7% until 2028.
  • FDA's focus on fast-tracking AI-based devices could expedite Ceribell's regulatory approvals.

What critics are saying

  • Emerging AI-powered EEG technologies could threaten Ceribell's market share.
  • Regulatory scrutiny on AI-powered devices may lead to delays and increased compliance costs.
  • Supply chain vulnerabilities could impact production timelines and costs for Ceribell.

What makes Ceribell unique

  • Ceribell's EEG system offers instant results without needing a specialist interpreter.
  • The Brain Stethoscope function converts brainwaves to sound for easier seizure detection.
  • Ceribell's system can be set up by any healthcare provider in just 6 minutes.

Help us improve and share your feedback! Did you find this helpful?